ES2584184T3 - Equipo para el tratamiento extracorporal de la sangre - Google Patents

Equipo para el tratamiento extracorporal de la sangre Download PDF

Info

Publication number
ES2584184T3
ES2584184T3 ES14198204.1T ES14198204T ES2584184T3 ES 2584184 T3 ES2584184 T3 ES 2584184T3 ES 14198204 T ES14198204 T ES 14198204T ES 2584184 T3 ES2584184 T3 ES 2584184T3
Authority
ES
Spain
Prior art keywords
blood
fraction
human
circuit
reaction chamber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14198204.1T
Other languages
English (en)
Spanish (es)
Inventor
Jakki Cooney
Todd Fumio Kagawa
Edmond Magner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Limerick
Original Assignee
University of Limerick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Limerick filed Critical University of Limerick
Application granted granted Critical
Publication of ES2584184T3 publication Critical patent/ES2584184T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0047—Enzymes, e.g. urokinase, streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A61M1/3689—Chemical treatment by biological cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/2111—C5a peptidase (3.4.21.110)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • External Artificial Organs (AREA)
ES14198204.1T 2013-12-17 2014-12-16 Equipo para el tratamiento extracorporal de la sangre Active ES2584184T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13197790 2013-12-17
EP13197790.2A EP2886140A1 (de) 2013-12-17 2013-12-17 Vorrichtung zur extrakorporalen Behandlung von Blut

Publications (1)

Publication Number Publication Date
ES2584184T3 true ES2584184T3 (es) 2016-09-26

Family

ID=49816857

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14198204.1T Active ES2584184T3 (es) 2013-12-17 2014-12-16 Equipo para el tratamiento extracorporal de la sangre

Country Status (3)

Country Link
US (4) US9422541B2 (de)
EP (2) EP2886140A1 (de)
ES (1) ES2584184T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11014088B2 (en) * 2016-03-09 2021-05-25 The Board Of Regents Of The University Of Texas System Sensitive ELISA for disease diagnosis on surface modified poly(methyl methacrylate) (PMMA) microfluidic microplates
US20190247560A1 (en) * 2018-02-13 2019-08-15 Gambro Lundia Ab Extracorporeal devices and methods of treating complement factor related diseases
US20210386836A1 (en) * 2018-10-23 2021-12-16 University Of Limerick Treatment of immune dysregulation disorders
EP3669888A1 (de) * 2018-12-20 2020-06-24 Gambro Lundia AB Extrakorporale vorrichtungen für verfahren zur behandlung von erkrankungen im zusammenhang mit zytoplasmischen anti-neutrophil-antikörpern
US11103628B1 (en) * 2020-04-29 2021-08-31 Orth Consulting, Llc Blood processing apparatus and method for detoxifying bacterial lipopolysaccharide
US10881781B1 (en) * 2020-04-29 2021-01-05 Orth Consulting, Llc Blood processing apparatus and method for detoxifying bacterial lipopolysaccharide
US11389581B1 (en) * 2021-06-29 2022-07-19 Orth Consulting, Llc Blood processing apparatus and method for preventing cancer metastasis

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605394A (en) * 1982-12-03 1986-08-12 Simon V. Skurkovich Methods for the treatment of pathological conditions by removing interferon from the organism
US4885207A (en) * 1987-07-13 1989-12-05 Uop Biocompatible protein or ligand immobilization system
US5451504A (en) * 1991-07-29 1995-09-19 Serex, Inc. Method and device for detecting the presence of analyte in a sample
US5817042A (en) * 1992-03-04 1998-10-06 Cobe Laboratories, Inc. Method and apparatus for controlling concentrations in vivos and in tubing systems
AU2191795A (en) * 1994-03-23 1995-10-09 Alexion Pharmaceuticals, Inc. Method for reducing immune and hemostatic dysfunctions during extracorporeal circulation
US5846547A (en) * 1996-01-22 1998-12-08 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
US20030003223A1 (en) * 2001-04-07 2003-01-02 The Regents Of The University Of California Methods and compositions for binding histidine-containing proteins to substrates
ATE415412T1 (de) * 2001-08-10 2008-12-15 Novartis Pharma Gmbh Peptide, die atherosklerotische schädigungen binden
WO2005115357A2 (en) * 2004-05-14 2005-12-08 Hans-Dietrich Polaschegg Taurolidine formulations and delivery
US20080260763A1 (en) * 2004-07-01 2008-10-23 The Regents Of The University Of California High Throughput Proteomics
US7282373B2 (en) * 2004-12-23 2007-10-16 Rutgers, The State University Of New Jersey Ultra-high specificity fluorescent labeling
SG10201503055TA (en) * 2006-07-05 2015-06-29 Catalyst Biosciences Inc Protease screening methods and proteases identified thereby
AU2009296393A1 (en) 2008-09-26 2010-04-01 Genentech, Inc. Methods for treating, diagnosing, and monitoring lupus
CA2738930C (en) * 2008-09-30 2021-08-17 The Trustees Of The University Of Pennsylvania Method of inhibiting biomaterial-induced procoagulant activity using complement inhibitors
US8430831B2 (en) * 2009-02-25 2013-04-30 The Invention Science Fund I, Llc Device, system, and method for controllably reducing inflammatory mediators in a subject
JP2014500735A (ja) * 2010-10-15 2014-01-16 サイトフェリックス インコーポレイテッド サイトフェレーシスカートリッジおよびその使用
KR20120099315A (ko) * 2011-01-26 2012-09-10 삼성전자주식회사 3-하이드록시프로피온산 및 1,3-프로판디올 동시 생산용 재조합미생물
GB201305708D0 (en) * 2013-03-28 2013-05-15 Clasado Inc Novel use

Also Published As

Publication number Publication date
EP2886142B1 (de) 2016-05-25
US20220054731A1 (en) 2022-02-24
EP2886140A1 (de) 2015-06-24
US20160354534A1 (en) 2016-12-08
EP2886142A1 (de) 2015-06-24
US20150166978A1 (en) 2015-06-18
US20200121846A1 (en) 2020-04-23
US9422541B2 (en) 2016-08-23

Similar Documents

Publication Publication Date Title
ES2584184T3 (es) Equipo para el tratamiento extracorporal de la sangre
ES2720200T3 (es) Procedimientos de purificación de ARN
DE3382834D1 (de) Sorbentmittel und dessen Herstellungsverfahren
ES2898875T3 (es) Dispositivo de preparación de muestras
RU2514956C2 (ru) Сорбент для диализа
US20140273058A1 (en) Integrated Membrane for Preservation of Biomolecules
BR112013013325A2 (pt) dispositivo e método para simultaneamente extrair e fracionar dna de lisado ou amostra integral e para fabricar dispositivo microfluídico
Chaiken Affinity chromatography and biological recognition
Rassin AMINO ACIDS AS PUTATIVE TRANSMITTERS: FAILURE TO BIND TO SYNAPTIC VESICLES OF GUINEA PIG CEREBRAL CORTEX 1
JPH11505325A (ja) 電気泳動のための装置及び方法
Juyi et al. Analysis of the chemical components of hydatid fluid from Echinococcus granulosus
KR20070001927A (ko) 분획 장치 및 분획 방법
EP3570848B1 (de) Nasale pharmazeutische zusammensetzungen zur verringerung der aussetzung von luftschadstoffen
SK67895A3 (en) Displacement chromatography process and purified hemoglobin product
AU2003249231A1 (en) Low dead volume extraction column devices
ES2940957T3 (es) Método de preparación de la muestra
WO2002067956A3 (en) Method for purifying a biological composition
ES2975131T3 (es) Metodo para la separacion de composiciones virales que incluyen agotamiento y purificacion de las mismas
ES2249440T3 (es) Camara con orificios para el acceso de una pipeta.
BR9807579A (pt) Aparelhagem de fluxo contìnuo para separação de substâncias carregadas em meio lìquido por focalização isoelétrica, processo para separação ou de purificação de uma substância a partir de uma mistura aquosa, substância purificada, vacina ou kit para teste, enzima hidrolìtica purificada, e, usos de uma enzima e de fetilase.
US10717022B2 (en) Integrated membrane device
CA2381340A1 (en) Method for isolating and purifying grass pollen allergens
Bradshaw Proteins in Biology and Medicine
Niwa et al. Therapeutic Application of Phenylalanine Immunoadsorbent with On‐Line Regeneration
JP2004089673A (ja) 花粉アレルゲンの不活性化方法